Delay in hospital admission after acute stroke;Retraso en la hospitalizacion del paciente con ictus agudo

Revista de Neurologia

Volumn 27, Issue 160, 1998, Pages 947-951

  Geffner, D ^a,c   Lago, A ^b   Tembl, J ^b   Vilar, C ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c NONE   (Spain)

Author keywords

Acute stroke; Hospital referral; Time delay; Time factors

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEX DIFFERENCE; SPAIN; STROKE; TIME; TRANSIENT ISCHEMIC ATTACK; ACUTE DISEASE; CEREBROVASCULAR DISEASE; HOSPITALIZATION; RETROSPECTIVE STUDY;

ACUTE DISEASE; AGED; CEREBROVASCULAR DISORDERS; FEMALE; HOSPITALIZATION; HUMANS; MALE; PATIENT ADMISSION; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0032418774     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.27160.98226     Document Type: Article

References (35)

1. Pulsinelli W. Pathophysiology of acute ischemic stroke. Lancet 1992; 339: 533-6.
2. Grotta J. A glimpse to the future: multitherapy trials. Cerebrovasc Dis 1995; 5 (Suppl 1): 27-30.
3. Adams HP Jr, Brott TG, Crowell RM, Furlan AJ, Gómez CR, Grotta J, et al. Guidelines for the management of patients with acute ischemic stroke. A statement for Healthcare professionals from a special writing Group of the Stroke Council, American Heart Association. Circulation 1994; 90: 1588-601.
4. Grupo de Estudio de las Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Manejo del paciente con enfermedad vascular cerebral aguda. Recomendaciones 1992. Barcelona: EDOS; 1992.
5. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol 1994; 36: 557-65.
6. Ringelstein EB, Biniek R, Weiller C, Ammeling B, Nolte PN, Thron. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992; 42: 289-98.
7. Donnan GA, Hommel M, Davis SM, McNeil JJ. Streptokinase in acute ischaemic stroke. Lancet 1995; 346: 56.
8. Del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, et al. Recombinant tissue plasminogen activator in acute thrombotic and embolie stroke. Ann Neurol 1992; 32: 78-86.
9. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, et al. Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992; 23: 632-40.
10. Haley EC Jr, Levy DE, Brott TG, Sheppard GL, Wong MCW, Kongable GL, et al. Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992; 23: 641-5.
11. Multicentre Acute Stroke Trial-Italy (MAST-I) group. Randomized controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischaemic stroke. Lancet 1995; 346: 1509-14.
12. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, Kummer RV, et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
13. The American Nimodipine Study Group. Clinical trial of nimodipine in acute ischemic stroke. Stroke 1992; 23: 3-8.
14. Trust study group. Randomized double-blind, placebo-controlled trial of nimodipine in acute stroke. Lancet 1990; 336: 1205-9.
15. Anderson NE, Broad JB, Bonita R. Delays in hospital admission and investigation in acute stroke. Br Med J 1995; 311: 162.
16. Kay R, Woo J, Poon WS. Hospital arrival time after onset of stroke. J Neurol Neurosurg Psychiatry 1992; 55: 973-4.
17. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Factors delaying hospital admission in acute stroke: the Copenhagen stroke study. Neurology 1996; 47: 383-7.
18. Alberts MJ, Bertels C, Dawson DV. An analysis of time of presentation after stroke. JAMA 1990; 263: 65-8.
19. Feldman E, Gordon N, Brooks JM, Brass LM, Fayad PB, Sawaya KL, et al. Factors associated with early presentation of acute stroke. Stroke 1992; 23: 1805-10.
20. Barer D, Main A, Lodwick R. Practicability of early treatment of acute stroke. Lancet 1992; 339: 1540-1.
21. Barsan WG, Brott TG, Broderick JP, Clarke Haley E, Levy DE, Marier JR. Time of hospital presentation in patients with acute stroke. Arch Intern Med 1993; 153: 2558-61.
22. Barsan WG, Brott TG, Broderick JP, Haley EC Jr, Levy DE, Marier JR. Urgent therapy for acute stroke. Effects of a stroke trial on untreated patients. Stroke 1994; 25: 2132-7.
23. Fogelholm R, Murros K, Rissanen A, Ilmavirta M. Factors delaying hospital admission after acute stroke. Stroke 1996; 27: 398-400.
24. Harper GD, Haigh RA, Potter JF, Castleden CM. Factors delaying hospital admission after stroke in Leicestershire. Stroke 1992; 23: 835-8
25. Castillo J, Dávalos A, Martínez-Vila E, por el Grupo de Estudio de las Enfermedades Cerebrovasculares de la Sociedad Española de Neurología. Tiempos de latencia en la atención de los pacientes con enfermedades cerebrovasculares agudas. Estudio multicéntrico. Rev Neurol 1996; 24: 427-30.
26. Dávalos A, Castillo J, Martínez-Vila E, by the Cerebrovascular Diseases Study Group of the Spanish Society of neurology. Delay in neurological attention and stroke outcome. Stroke 1995; 25: 2233-7.
27. Rey A, Martí-Vilalta JL. Latencia de ingreso hospitalario en patología vascular cerebral: factores determinantes. Rev Neurol 1996; 24: 431-4.
28. Ferro JM, Melo TP, Oliveira V, Crespo M, Canhao, Pinto AN. An analysis of the admission delay of acute strokes. Cerebrovasc Dis 1994; 4: 72-5.
29. Whisnant JP, Basford JR, Bernstein EF, et al. Special report from the national institute of neurological disorders and stroke. Classification of cerebrovascular diseases III. Stroke 1990; 21: 637-76.
30. Aho K, Harmsen P, Hatano S, Marquardsen J, Smirnov VE, Strasser T, on behalf of the participants in the WHO Collaborative Study on the control of Stroke in the Community. Cerebrovascular disease in the community: results of a WHO collaborative study. Bulletin of WHO 1980; 58: 113-30.
31. Bamford J, Sandercock P, Jones L, Warlow C. The natural history of lacunar infarction: the Oxfordshire Community stroke project. Stroke 1987; 18: 545-51.
32. Davis SM, Donnan A. Patients, centers, admission procedures and non-randomized treatments around the world. Cerebrovasc Dis 1995; 5 (Suppl 1): 16-21.
33. Bamford J, Sandercock P, Warlow C. Why are patients with acute stroke admitted to hospital? Br Med J 1986; 292: 1369-72.
34. López-Pousa S, Vilalta JF, Lins Regla J. Epidemiología de la enfermedad vascular cerebral en Girona. En López Pousa S, García JH, Álvarez Sabin J, Lahoz CH, eds. Enfermedad vascular cerebral. Barcelona: Laboratorios Uriach; 1994.
35. Geffner D, Lago A, Teruel C, Salas R, Cerdá J, Vilar V. Enfermedad vasculocerebral aguda atendida en el Servicio de Urgencias del Hospital General de Castellón. Rev Neurol 1995; 23: 311-4.